| Imatinib studied in …STUDIED_INderived174 of 174show fewer |
|---|
| → studied in | NCT06090669Phase 1 · recruiting Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06124157Phase 2 · recruiting A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) · 174 trials list this drug (36 active) | — | — | B Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07585266Phase 3 · recruiting A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline) · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05152472Phase 2 · recruiting A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05816785early Phase 1 · completed Pilot Study of Imatinib Cetuximab Combo for H & N Cancer · 174 trials list this drug (36 active) | — | — | Malignant Head and Neck Neoplasm,Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03722420Phase 3 · active not recruiting Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China) · 174 trials list this drug (36 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05493215Phase 2 · recruiting Imatinib TDM in GIST · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04971226Phase 3 · active not recruiting A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04838041Phase 2 · recruiting Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation · 174 trials list this drug (36 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03906292Phase 2 · active not recruiting Frontline Asciminib Combination in Chronic Phase CML · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04598009Phase 2 · recruiting Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma · 174 trials list this drug (36 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04307576Phase 3 · recruiting A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia · 174 trials list this drug (36 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07406633Phase 2 · recruiting KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line) · 174 trials list this drug (36 active) | — | — | Digestive System Neoplasm,Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04877522Phase 4 · recruiting Asciminib Roll-over Study · 174 trials list this drug (36 active) | — | — | Leukemia,Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05413915Phase 3 · terminated Asciminib Used in Consolidation With Imatinib vs. Imatinib to Achieve TFR in CP-CML · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07171203Phase 1 · recruiting Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03578367Phase 2 · completed Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response. · 174 trials list this drug (36 active) | — | — | Leukemia,Myeloid Leukemia,Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07493408Phase 2 · not yet recruiting Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00044304Phase 2 · active not recruiting Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00421317Phase 2 · terminated Imatinib in Adult Patients With Metastatic Ocular Melanoma · 174 trials list this drug (36 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05245968Phase 1 · active not recruiting A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101) · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03654768Phase 2 · active not recruiting Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia · 174 trials list this drug (36 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02881086Phase 3 · completed Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment · 174 trials list this drug (36 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01991379Phase 1/Phase 2 · active not recruiting MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST) · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03589326Phase 3 · active not recruiting A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04070443Phase 2 · active not recruiting Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07022743Phase 2 · active not recruiting Improving Treatment Outcomes in Chronic Myeloid Leukaemia Patients Using Imatinib and Artesunate Combination Therapy · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05722795NA · recruiting Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC) · 174 trials list this drug (36 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03469011Phase 1 · terminated A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer. · 174 trials list this drug (36 active) | — | — | Thyroid Gland Papillary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00476190Phase 2 · completed ALL Adult Consortium Trial: Adult ALL Trial · 174 trials list this drug (36 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06962254Phase 1 · recruiting Imatinib and Trametinib for KRAS-mutated Solid Tumor · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05071482Phase 4 · terminated Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL · 174 trials list this drug (36 active) | — | — | Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06061094Phase 2 · recruiting Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03844360Phase 4 · recruiting Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease · 174 trials list this drug (36 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06119789Phase 2 · recruiting Precision Cancer Therapy in Rare Cancers · 174 trials list this drug (36 active) | — | — | Rare Childhood Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01804985Phase 2 · completed De- Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in Chronic Myeloid Leukaemia · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02413736Phase 3 · active not recruiting Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST · 174 trials list this drug (36 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06038552completed Comparison of Clinical Efficacy of Liver Resection, RFA, TACE, and Drug Therapy in Patients with GIST LM · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor,Malignant Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04423185Phase 2 · recruiting PLATFORM Study of Precision Medicine for Rare Tumors · 174 trials list this drug (36 active) | — | — | Rare Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06219733Phase 2 · withdrawn Vactosertib and Imatinib Combination in Patients with Advanced Desmoid Tumor/aggressive Fibromatosis (DT/AF) · 174 trials list this drug (36 active) | — | — | Dermoid Cyst | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06692491Phase 2 · not yet recruiting Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS · 174 trials list this drug (36 active) | — | — | Rare Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06646978enrolling by invitation Long-term Risk of Second Primary Malignancies for Chronic Myeloid Leukaemia in the French Imatinib-based SPIRIT Trial · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06628739completed Correlation Between Imatinib Trough Concentration and Efficacy in Advanced GIST Patients with Different Genotypes · 174 trials list this drug (36 active) | — | — | Malignant Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02326311Phase 3 · completed Optimization of TKIs Treatment and Quality of Life in Ph+ CML Patients ≥60 Years in Deep Molecular Response · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06336395Phase 2 · recruiting Ma-Spore ALL 2020 Study · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02081378Phase 1 · completed A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL · 174 trials list this drug (36 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · 174 trials list this drug (36 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01541709Phase 2 · unknown Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06175702not yet recruiting Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL · 174 trials list this drug (36 active) | — | — | Acute Lymphoblastic Leukemia,Adult Acute Lymphoblastic Leukemia,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03193281Phase 2 · unknown KISS Study: Kinase Inhibition With Sprycel Start up · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02352558Phase 1 · completed A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies · 174 trials list this drug (36 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05286528completed Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05009927Phase 2 · recruiting Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten) · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02365441Phase 2 · unknown A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST) · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01593254Phase 2 · completed Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib · 174 trials list this drug (36 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05895942unknown Exploring the Molecular Mechanism Based on KIT Mutation · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04138381Phase 1/Phase 2 · unknown Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST) · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor,Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02269267Phase 2 · completed The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study) · 174 trials list this drug (36 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00812240Phase 3 · terminated Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST) · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03885830completed Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01475110completed Observational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With Nilotinib · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01025505Phase 2 · completed Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational Study · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01319981Phase 2 · completed Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia · 174 trials list this drug (36 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02461849Phase 2 · unknown Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib Therapy · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03170180Phase 2 · completed Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer · 174 trials list this drug (36 active) | — | — | Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05367765Phase 4 · not yet recruiting A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase · 174 trials list this drug (36 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02462538Phase 1/Phase 2 · terminated Brentuximab Vedotin and Imatinib in Patients With Relapsed or Refractory ALK+ ALCL · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02602314Phase 4 · unknown Sustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid Leukemia · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01491763Phase 4 · unknown Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00038675NA · completed Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate · 174 trials list this drug (36 active) | — | — | Mastocytosis,Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Myelomonocytic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04933669Phase 2 · recruiting Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00171223Phase 2 · completed An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha · 174 trials list this drug (36 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00171249Phase 2 · completed An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia · 174 trials list this drug (36 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01275222Phase 1/Phase 2 · completed Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02130557Phase 3 · completed A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia · 174 trials list this drug (36 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01216085Phase 2 · completed An Exploratory Study of High-dose Glivec in Patients With CML-CP Using Molecular Endpoints · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03454503completed Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01827930Phase 3 · terminated Phase III Trial Evaluating the Effectiveness of a Dose Adjustment of Imatinib Mesylate on the Molecular Response · 174 trials list this drug (36 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04688983Phase 2 · unknown Study in Adult Ph-positive ALL · 174 trials list this drug (36 active) | — | — | Adult Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01468688Phase 1 · completed A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00471497Phase 3 · completed A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) · 174 trials list this drug (36 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04578847Phase 2 · unknown A Study of REduction And DIscontinuation Treatment of TKI (Imatinib, Nilotinib, Dasatinib and Bosutinib) · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00390156Phase 1 · completed Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors · 174 trials list this drug (36 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03131999Phase 1/Phase 2 · completed LAM Pilot Study With Imatinib Mesylate · 174 trials list this drug (36 active) | — | — | Lymphangioleiomyomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00219739Phase 3 · completed STI571 ProspectIve RandomIzed Trial: SPIRIT · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02638428Phase 2 · unknown Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy · 174 trials list this drug (36 active) | — | — | Childhood Solid Neoplasm,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01151852Phase 3 · completed Rechallenge of Imatinib in GIST Having no Effective Treatment: RIGHT · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02495519Phase 2 · completed A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis) · 174 trials list this drug (36 active) | — | — | Fibromatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00278876Phase 2 · completed Adjuvant Imatinib in High-risk Gastrointestinal Stromal Tumor (GIST) With C-kit Mutation · 174 trials list this drug (36 active) | — | — | Sarcoma,Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02174445Phase 3 · terminated An Open-label, Randomised Multicenter Phase 3b Study to Determine the Confirmed Rate of Molecular Response ≥ 4 Log (MR4) at Two Years · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02611492Phase 3 · unknown A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02685046Phase 2 · terminated Imatinib as Pre-operative Anti-Colon Cancer Targeted Therapy · 174 trials list this drug (36 active) | — | — | Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02272777Phase 3 · completed A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase · 174 trials list this drug (36 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00632255completed Long Term Therapy With Imatinib: Development of Late Side Effects and Compliance to Treatment · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03862768NA · unknown Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00574873Phase 3 · completed Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047502Phase 1 · completed Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia · 174 trials list this drug (36 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027586Phase 2 · completed Imatinib Mesylate in Treating Patients With Metastatic Melanoma · 174 trials list this drug (36 active) | — | — | Skin Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00415857Phase 2 · terminated Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R) · 174 trials list this drug (36 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03515018Phase 3 · unknown Evaluation of the Therapeutic Effect of HU Pulse Therapy for CML Patients · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01460693Phase 3 · completed Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia · 174 trials list this drug (36 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02204644Phase 3 · completed The Study of the Efficacy and the Safety of Flumatinib vs Imatinib as First Line Treatment in Patients With CML · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03381053unknown Study to Compare Pathologic Type, NIH and WHO Criteria,and Mechanism of GIST Malignant Transformation · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03228303early Phase 1 · unknown Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00852566Phase 2 · completed Randomized Study Comparing the Effect of Dasatinib and Imatinib on Malignant Stem Cells in Chronic Myeloid Leukemia · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079313Phase 2 · completed Imatinib (Gleevec(Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia · 174 trials list this drug (36 active) | — | — | Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01316458Phase 2 · completed Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy · 174 trials list this drug (36 active) | — | — | Neoplasm,Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01137916Phase 2 · completed Study to Evaluate Imatinib in Desmoid Tumors · 174 trials list this drug (36 active) | — | — | Desmoid Fibromatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00973752Phase 2 · completed Treatment of Older Adults With Acute Lymphoblastic Leukemia · 174 trials list this drug (36 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00150072Phase 2 · completed Efficacy and Safety of Imatinib in Chordoma · 174 trials list this drug (36 active) | — | — | Chordoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00481247Phase 3 · completed A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00585221Phase 2 · terminated Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients · 174 trials list this drug (36 active) | — | — | Solid Neoplasm,Gastrointestinal Stromal Tumor,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00424515Phase 2 · completed Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma · 174 trials list this drug (36 active) | — | — | Mucosal Melanoma,Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02977312completed Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan · 174 trials list this drug (36 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00760877Phase 3 · completed Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction (RQ-PCR) · 174 trials list this drug (36 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00845221Phase 4 · completed Glivec in Pediatric Chronic Myeloid Leukemia (CML) · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01188278completed Treatment With Second Generation Tyrosine Kinase Inhibitors (2G TKI) Post Imatinib Failure Survey · 174 trials list this drug (36 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02894645Phase 4 · unknown Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study · 174 trials list this drug (36 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02146846terminated Population Pharmacokinetics of Imatinib in CML Patients in Iran · 174 trials list this drug (36 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02013089NA · unknown A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC Study · 174 trials list this drug (36 active) | — | — | Malignant Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00785785Phase 3 · completed A Study of Nilotinib Versus Imatinib in GIST Patients · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00193180Phase 2 · completed Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer · 174 trials list this drug (36 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01275196Phase 3 · completed Safety and Efficacy of Nilotinib vs. Imatinib in the Treatment of Newly Diagnosed Chinese Ph+ CML-CP Patients · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00420043Phase 1 · completed Effect of Food on Bioavailability of Modified Release Formulations of Imatinib · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00422825Phase 1 · completed Effect of Food on Bioavailability of a Modified Release Formulation of Imatinib · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01511289Phase 3 · completed Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients · 174 trials list this drug (36 active) | — | — | Leukemia,Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00982488Phase 2 · completed Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia · 174 trials list this drug (36 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00802841Phase 3 · completed Randomized Phase Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib · 174 trials list this drug (36 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02576080Phase 3 · unknown Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01126814Phase 1/Phase 2 · completed A Study of Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia · 174 trials list this drug (36 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02480608Phase 1/Phase 2 · completed Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004) · 174 trials list this drug (36 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01188889Phase 1/Phase 2 · withdrawn RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease. · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02317159Phase 4 · unknown Efficacy and Safety of Imatinib Mesylate as First-line Treatment for the Patients With Chronic Phase of Chronic Myeloid Leukemia · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00858806Phase 2 · completed Intermittent Imatinib Treatment in Chronic Myeloid Leukemia and Philadelphia Chromosome (Ph+CML) Patients Who Achieved a Complete Cytogenetic Response (CCgR) on Standard Imatinib Therapy · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01650805Phase 3 · terminated Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC) · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01751919Phase 1 · completed A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I) · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor,Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00415909Phase 2 · terminated TALL-104 and Gleevec in Chronic Myelogenous Leukemia Patients · 174 trials list this drug (36 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02103322Phase 2/Phase 3 · completed Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor,Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00115739Phase 2 · terminated Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma · 174 trials list this drug (36 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00751036Phase 3 · terminated Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00376467Phase 2 · completed STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia · 174 trials list this drug (36 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00402662Phase 2 · terminated A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma · 174 trials list this drug (36 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00320190Phase 2 · terminated Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib · 174 trials list this drug (36 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01503502Phase 2 · unknown A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia · 174 trials list this drug (36 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01782508Phase 2 · unknown A Phase II Study of Imatinib Versus Interferon as Adjuvant Therapy in KIT-mutated Melanoma · 174 trials list this drug (36 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00193258Phase 1/Phase 2 · completed Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma · 174 trials list this drug (36 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01048320Phase 1 · completed Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic Cancer · 174 trials list this drug (36 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00088231Phase 1/Phase 2 · completed PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP · 174 trials list this drug (36 active) | — | — | Myeloid Leukemia,Acute Myeloid Leukemia,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00116935Phase 3 · completed Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST) · 174 trials list this drug (36 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00519090Phase 3 · terminated Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) · 174 trials list this drug (36 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00500188Phase 2 · completed Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00122473Phase 1/Phase 2 · completed Imatinib in Dermatofibrosarcoma Protuberans (DFSP) · 174 trials list this drug (36 active) | — | — | Dermatofibrosarcoma Protuberans | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00940563Phase 2 · completed A Prospective, Multicenter Study on Best Clinical Use of Imatinib in the Advanced Gastrointestinal Stromal Tumors · 174 trials list this drug (36 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00290771Phase 2 · terminated Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM) · 174 trials list this drug (36 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00881049Phase 2 · completed Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma · 174 trials list this drug (36 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00787384Phase 2 · completed Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes · 174 trials list this drug (36 active) | — | — | Chronic Eosinophilic Leukemia, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00103844Phase 2 · completed Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Myeloid Leukemia, Philadelphia-Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00193349Phase 2 · completed Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer · 174 trials list this drug (36 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00237120Phase 3 · completed Efficacy, Safety and Long-term Prognosis of Imatinib in Patients Newly Diagnosed With Chronic Myelogenous Leukemia (Chronic Phase) · 174 trials list this drug (36 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00362466Phase 3 · terminated A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy · 174 trials list this drug (36 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00276926Phase 2 · unknown Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias · 174 trials list this drug (36 active) | — | — | Myeloproliferative Neoplasm,Chronic Eosinophilic Leukemia, Not Otherwise Specified | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00707408Phase 2 · completed High-Dose Imatinib for Relapsed/Refractory c-Kit Positive Acute Myelogenous Leukemia (AML) · 174 trials list this drug (36 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00130195Phase 2 · completed Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) · 174 trials list this drug (36 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00199186Phase 2 · unknown Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL) · 174 trials list this drug (36 active) | — | — | B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00180921Phase 2 · unknown Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck · 174 trials list this drug (36 active) | — | — | Malignant Head and Neck Neoplasm,Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00514488Phase 3 · completed Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day) · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00514969Phase 2 · completed Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia in Accelerated and Blastic Phase · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00510926Phase 2 · completed Exploratory Study of IMATINIB High Dose in Intermediate Risk Chronic Myeloid Leukemia in Chronic Phase · 174 trials list this drug (36 active) | — | — | Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00511303Phase 2 · completed Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00146913Phase 2 · unknown AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00149136Phase 2 · unknown Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy. · 174 trials list this drug (36 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00327262Phase 3 · unknown Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00219752Phase 2 · completed Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00219765Phase 1/Phase 2 · terminated Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients · 174 trials list this drug (36 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |